Some research suggests that GLP-1 receptor agonists may increase sympathetic tone or decrease parasympathetic activity, which could lead to a modest elevation in resting heart rate
GLP-1RAs appear to offer a potential dual therapeutic advantage, simultaneously targeting metabolic dysfunction and immune-mediated inflammation, thereby representing a potentially promising strategy in the management of early-stage PsA early PsA, although robust clinical evidence in this setting is currently lacking
Conley M
In a mouse model of hepatocellular carcinoma induced by diethylnitrosamine (DEN), liver GCN5L1 knockout increased DEN sensitivity in the model
This article explores the mechanisms behind skin changes during Ozempic use and provides practical guidance on managing these effects
In wound healing, GHK-Cu reduces healing time by 30 to 50 percent across surgical wounds, chronic ulcers, and traumatic injuries